Privigen 10% vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGER0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,955
Award facts
- Contract value 100% obligated
- $35,955.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,955 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for PRIVIGEN 10% Vial 400ML. The contract, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, carries no set-aside designation and was fulfilled without subcontractor involvement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to Department of Defense medical facilities worldwide.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036, establishes the company as a critical regional prime vendor contractor within the DoD's pharmaceutical supply chain. Through this vehicle, DMS Pharmaceutical Group supplies a comprehensive range of branded and generic prescription medications, biologics, vaccines, and medical consumables to support military healthcare operations globally. The company's demonstrated performance on numerous prior delivery orders reflects its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FGER0?
SPE2DR26FGER0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FGER0 worth?
The government has obligated $35,955 on SPE2DR26FGER0.
Is contract SPE2DR26FGER0 an order under another contract?
Yes. SPE2DR26FGER0 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGER0 competed?
The extent of competition for SPE2DR26FGER0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award